You are here: Home > News > Innovation by Artificial Intelligence and the role of AI in pharmaceutical discovery

Innovation by Artificial Intelligence and the role of AI in pharmaceutical discovery

31 May 2019

Through the ability of Artifical Intelligence, the health care sector can find solutions to effective treatment to cure diseases.

 

Partner, Adrian Tombling explores why AI is huge for drug research and what impact this could have on the pharmaceutical industry.

As AI is created by a computer, it does raise the question, who owns the IP? In this second video, Adrian answers this exact question.

Adrian Tombling
Life Sciences and Chemistry group

If you require further information on anything covered in this briefing, please contact Adrian Tombling (atombling@withersrogers.com; +49 89 50222 4020) or your usual contact at the firm. This video is a general summary of the law. It should not replace legal advice tailored to your specific circumstances.